SCHEMBL7306023

SCHEMBL7306023

CCN(CC)C(=O)N(C)CC1(c2ccccc2)CCN(Cc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.52
OPRL1 P41146 1/20 0.48
POLB P06746 1/20 0.47
NPFFR1 Q9GZQ6 1/20 0.47
NPFFR2 Q9Y5X5 1/20 0.47
CYP2D6 P10635 3/20 0.46
OPRM1 P35372 4/20 0.46
SIGMAR1 Q99720 2/20 0.46
ACHE P22303 2/20 0.45
BCHE P06276 1/20 0.45
KDM4E B2RXH2 1/20 0.44
KCNA3 P22001 1/20 0.43
CHRM2 P08172 2/20 0.43
CHRM3 P20309 1/20 0.43
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630028 0.89 CACNA1G (0.54) CACNA1GOPRL1POLBNPFFR1NPFFR2
SCHEMBL4629996 0.85 CACNA1G (0.55) CACNA1GOPRL1POLBNPFFR1NPFFR2
SCHEMBL7304290 0.83 NPFFR1 (0.53) CACNA1GOPRL1POLBNPFFR1NPFFR2
SCHEMBL4631201 0.83 BCHE (0.52) CACNA1GOPRL1POLBNPFFR1NPFFR2
SCHEMBL7305853 0.79 OPRM1 (0.45) OPRL1CYP2D6OPRM1KCNA3CHRM2
SCHEMBL7304297 0.78 NPFFR1 (0.59) CACNA1GOPRL1POLBNPFFR1NPFFR2
SCHEMBL2808174 0.74 OPRL1 (0.54) CACNA1GOPRL1OPRM1SIGMAR1KDM4E
SCHEMBL10254909 0.73 OPRL1 (0.58) OPRL1POLBNPFFR1NPFFR2CYP2D6
SCHEMBL2789160 0.72 OPRL1 (0.66) OPRL1POLBNPFFR1NPFFR2CYP2D6
SCHEMBL4630841 0.72 NPFFR1 (0.51) OPRL1POLBNPFFR1NPFFR2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294537-B1 NEUROKININS USED FOR TREATMENT OF DISEASES SANOFI-SYNTHELABO (FR) 2001-09-25 US disclosed
US-5942523-A NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES SANOFI (FR) 1999-08-24 US disclosed
US-5741910-A PIPERIDINE DERIVATIVE INTERMEDIATES SANOFI (FR) 1998-04-21 US disclosed
EP-0673928-A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists SANOFI (FR) 1995-09-27 EP disclosed